These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 20422941

  • 1. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
    Zhang H, Wang W, Jiang Z, Shang J, Zhang L.
    Arzneimittelforschung; 2010; 60(3):109-15. PubMed ID: 20422941
    [Abstract] [Full Text] [Related]

  • 2. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
    [Abstract] [Full Text] [Related]

  • 3. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.
    Tatarczyńska E, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E.
    Eur J Pharmacol; 2004 Mar 08; 487(1-3):133-42. PubMed ID: 15033385
    [Abstract] [Full Text] [Related]

  • 4. Role of 5-HT(1A) and 5-HT(1B) receptors in the antidepressant-like effect of piperine in the forced swim test.
    Mao QQ, Huang Z, Ip SP, Xian YF, Che CT.
    Neurosci Lett; 2011 Oct 24; 504(2):181-184. PubMed ID: 21964383
    [Abstract] [Full Text] [Related]

  • 5. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
    Rénéric JP, Bouvard M, Stinus L.
    Neuropsychopharmacology; 2001 Apr 24; 24(4):379-90. PubMed ID: 11182533
    [Abstract] [Full Text] [Related]

  • 6. Effect of co-administration of the selective 5-HT1A receptor antagonist WAY 100,635 and selective 5-HT1B/1D receptor antagonist GR 127,935 on anxiolytic effect of citalopram in conditioned fear stress in the rat.
    Muraki I, Inoue T, Koyama T.
    Eur J Pharmacol; 2008 May 31; 586(1-3):171-8. PubMed ID: 18423441
    [Abstract] [Full Text] [Related]

  • 7. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test.
    Dias Elpo Zomkowski A, Oscar Rosa A, Lin J, Santos AR, Calixto JB, Lúcia Severo Rodrigues A.
    Brain Res; 2004 Oct 15; 1023(2):253-63. PubMed ID: 15374751
    [Abstract] [Full Text] [Related]

  • 8. Role of 5-HT(1A) and 5-HT(1B) receptors in the mediation of behavior in the forced swim test in mice.
    O'Neill MF, Conway MW.
    Neuropsychopharmacology; 2001 Apr 15; 24(4):391-8. PubMed ID: 11182534
    [Abstract] [Full Text] [Related]

  • 9. Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.
    Egashira N, Matsuda T, Koushi E, Higashihara F, Mishima K, Chidori S, Hasebe N, Iwasaki K, Nishimura R, Oishi R, Fujiwara M.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):117-21. PubMed ID: 18565508
    [Abstract] [Full Text] [Related]

  • 10. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
    Knobelman DA, Hen R, Blendy JA, Lucki I.
    J Pharmacol Exp Ther; 2001 Sep 28; 298(3):1092-100. PubMed ID: 11504806
    [Abstract] [Full Text] [Related]

  • 11. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
    Dawson LA, Nguyen HQ.
    Neuropharmacology; 2000 Apr 03; 39(6):1044-52. PubMed ID: 10727715
    [Abstract] [Full Text] [Related]

  • 12. Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.
    Guptarak J, Sarkar J, Hiegel C, Uphouse L.
    Horm Behav; 2010 Jul 03; 58(2):290-6. PubMed ID: 20223238
    [Abstract] [Full Text] [Related]

  • 13. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
    Martínez-Mota L, Estrada-Camarena E, López-Rubalcava C.
    Psychopharmacology (Berl); 2002 Dec 03; 165(1):60-6. PubMed ID: 12474119
    [Abstract] [Full Text] [Related]

  • 14. Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test.
    Estrada-Camarena E, Fernández-Guasti A, López-Rubalcava C.
    Neuropsychopharmacology; 2006 Feb 03; 31(2):247-55. PubMed ID: 16012533
    [Abstract] [Full Text] [Related]

  • 15. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors.
    Wang R, Xu Y, Wu HL, Li YB, Li YH, Guo JB, Li XJ.
    Eur J Pharmacol; 2008 Jan 06; 578(1):43-50. PubMed ID: 17942093
    [Abstract] [Full Text] [Related]

  • 16. 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.
    Moser PC, Sanger DJ.
    Eur J Pharmacol; 1999 May 14; 372(2):127-34. PubMed ID: 10395092
    [Abstract] [Full Text] [Related]

  • 17. Diabetes attenuates the antidepressant-like effect mediated by the activation of 5-HT1A receptor in the mouse tail suspension test.
    Miyata S, Hirano S, Kamei J.
    Neuropsychopharmacology; 2004 Mar 14; 29(3):461-9. PubMed ID: 14628002
    [Abstract] [Full Text] [Related]

  • 18. 5-HT(1A) and 5-HT(1B) receptors in the ventrolateral striatum differentially modulate apomorphine-induced jaw movements in rats.
    Fujita S, Kiguchi M, Lee J, Terakado M, Suga K, Hatanaka H, Koshikawa N.
    J Oral Sci; 2008 Dec 14; 50(4):387-95. PubMed ID: 19106465
    [Abstract] [Full Text] [Related]

  • 19. In vivo/ex vivo and behavioural study on central effects of 5-HT1B/1D and 5-HT1A antagonists in guinea pigs.
    Rex A, Voigt JP, Wicke KM, Fink H.
    Pharmacol Biochem Behav; 2008 Jan 14; 88(3):196-204. PubMed ID: 17888505
    [Abstract] [Full Text] [Related]

  • 20. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I.
    J Pharmacol Exp Ther; 2002 Sep 14; 302(3):1220-7. PubMed ID: 12183683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.